Clinical observation on the treatment of non-motor symptoms of Parkinson's disease with Shudi Pingchan prescription combined with repetitive transcranial magnetic stimulation

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ITMCTR

Registry ID

ITMCTR2000003724

Enrollment

Unknown

Registered

2020-08-26

Start date

2021-01-01

Completion date

Unknown

Last updated

2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease

Interventions

rTMS group:rTMS

TCM group:Sudi Pingchan granules+Pseudo stimulus

Comprehensive treatment group:Sudi Pingchan granules+rTMS

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) It meets the diagnostic criteria of Western medicine and Traditional Chinese medicine for Parkinson's disease, and the H-Y grading is <= 4; (2) Parkinson's disease with non-motor symptoms (NMS), including sleep disorders, depression, anxiety and autonomic nervous dysfunction; (3) Participate voluntarily and sign informed consent.

Exclusion criteria

Exclusion criteria: (1) Secondary Parkinson's disease; (2) Patients with serious heart, lung, kidney diseases or mental illness; (3) Those with a history of epilepsy; (4) Having a heart pacemaker or other metal implants installed.

Design outcomes

Primary

Measure	Time frame
CPC Sleep Quality Assessment and Analysis System;UPDRS I-IV;	—

Secondary

Measure	Time frame
HAMD;PDQ-39;Non-motor Symptoms Assessment Scale for Parkinson's Disease;Improved Hoehn Yahr grading;HAMA;SCOPA-AUT;PDSS;Levodopa dosage;	—

Countries

China

Contacts

Public ContactQing Ye

Longhua Hospital Shanghai University of Traditional Chinese Medicine

Yeqing1982889@163.com+86 13636304576

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026